VBLT - VBL Therapeutics GAAP EPS of -$0.45 misses by $0.03 revenue of $0.77M beats by $0.02M
VBL Therapeutics press release (NASDAQ:VBLT): FY GAAP EPS of -$0.45 misses by $0.03. Revenue of $0.77M (-16.3% Y/Y) beats by $0.02M. At December 31, 2021, cash, cash equivalents, short-term bank deposits and restricted bank deposits of $53.5 million.
For further details see:
VBL Therapeutics GAAP EPS of -$0.45 misses by $0.03, revenue of $0.77M beats by $0.02M